Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
HACKENSACK, NJ / ACCESSWIRE / October 16, 2024 /Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, is pleased to announce a licensing agreement with Weill Cornell Medicine through the Center for Technology Licensing (CTL), part of Enterprise Innovation at Weill Cornell Medicine. This strategic collaboration will allow Champions Oncology to distribute and commercialize Weill Cornell Medicine's extensive bank of hematological patient-derived xenograft (PDX) models, generated by Dr. Giorgio Inghirami, Professor of Pathology and Laboratory Medicine at the institution and a member of the Englander Institute for Precision Medicine and Sandra and Edward Meyer Cancer Center.
Through this agreement, Champions Oncology will hold exclusive rights, for a limited time, to offer services leveraging Weill Cornell Medicine's models, and will serve as a repository to distribute these models to academic institutions worldwide. This collaboration enhances Champions Oncology's commitment to providing cutting-edge solutions in the heme-oncology space.
"We are thrilled to be chosen to collaborate with Weill Cornell Medicine," said Ronnie Morris, MD, CEO at Champions Oncology. "Dr. Inghirami is globally renowned for his expertise in generating hematological PDX models. The addition of these models to our portfolio will further solidify our position as a leader in the heme-oncology field. Our extensive experience in commercializing clinically relevant, pretreated hematological models will ensure rapid and scalable access to these unique PDXs for both our biopharma partners and academic institutions."
The Center for Technology Licensing at Weill Cornell Medicine played a crucial role in negotiating the licensing agreement and brokering this relationship with Champions Oncology as part of Enterprise Innovation's mission to accelerate the best of biomedical innovation to market and translate groundbreaking research by Weill Cornell Medicine faculty into transformational care solutions. Enterprise Innovation provides a bridge between academic researchers and industry stakeholders.
About Champions Oncology
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Inquiries:
Rachel Bunting, MS, MBA VP, Global MarketingMarketing@ChampionsOncology.com
Website: https://www.championsoncology.com/ Facebook: https://www.facebook.com/championsoncology/ LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/ X: @ChampionsOncol1 Instagram: https://www.instagram.com/championsoncology/
SOURCE: Champions Oncology, Inc.
View the original press release on accesswire.comShares of Champions Oncology, Inc. rose sharply in today's pre-market trading reported better-than-expected financial results for the first quarter on Wednesday.
The company reported quarterly earnings of 11 cents per share which beat the analyst consensus estimate of a loss of $0.3 per share.
Champions Oncology shares jumped 13.5% to $4.55 in the pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
Losers
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
September S&P 500 E-Mini futures (ESU24) are up +0.24%, and September Nasdaq 100 E-Mini futures are up +0.27% this morning as investors braced for crucial U.S. producer inflation data while also awaiting the European Central Bank’s interest rate decision.
In yesterday’s trading session, Wall Street’s major indices closed in the green. Solar stocks soared after Wall Street largely declared Vice President Kamala Harris, who is viewed as a supporter of the energy transition, the winner of Tuesday night’s debate with former President Donald Trump, with First Solar surging over +15% to lead gainers in the S&P 500 and Enphase Energy rising more than +5%. Also, chip stocks gained ground, with Arm climbing over +10% to lead gainers in the Nasdaq 100 and Nvidia advancing more than +8%. In addition, Albemarle gained over +13% after a Reuters report indicated that Chinese battery producer CATL plans to cut lithium production levels. On the bearish side, GameStop tumbled about -12% after the videogame retailer reported weaker-than-expected Q2 revenue.
The U.S. Bureau of Labor Statistics report released on Wednesday showed that consumer prices increased +0.2% m/m in August, in line with expectations. On an annual basis, headline inflation cooled to +2.5% in August from +2.9% in July, in line with expectations and the smallest increase in 3-1/2 years. At the same time, the core CPI, which excludes volatile food and fuel prices, advanced +0.3% m/m and +3.2% y/y in August, compared to expectations of +0.2% m/m and +3.2% y/y.
“This isn’t the CPI report the market wanted to see,” said Seema Shah at Principal Asset Management. “The number is certainly not an obstacle to policy action next week, but the hawks on the committee will likely seize on [the August] CPI report as evidence that the last mile of inflation needs to be handled with care and caution.”
Meanwhile, U.S. rate futures have priced in an 87.0% probability of a 25 basis point rate cut and a 13.0% chance of a 50 basis point rate cut at the upcoming monetary policy meeting.
Today, all eyes are focused on the U.S. Producer Price Index, set to be released in a couple of hours. Economists, on average, forecast that the U.S. August PPI will come in at +0.1% m/m and +1.8% y/y, compared to the previous figures of +0.1% m/m and +2.2% y/y.
The U.S. Core PPI will also be closely watched today. Economists expect August figures to be +0.2% m/m and +2.5% y/y, compared to the previous numbers of 0.0% m/m and +2.4% y/y.
U.S. Initial Jobless Claims data will be reported today as well. Economists predict this figure will hold steady at 227K, consistent with last week’s number.
On the earnings front, Photoshop maker Adobe is scheduled to report its Q3 earnings results today.
In the bond market, the yield on the benchmark 10-year U.S. Treasury note is at 3.676%, up +0.69%.
The Euro Stoxx 50 futures are up +1.15% this morning, fueled by a global tech rally, while investors awaited the European Central Bank’s latest monetary policy decision. Technology and mining stocks led the gains on Thursday. Data from the National Statistics Institute released Thursday showed that Spain’s annual inflation rate stood at 2.3% in August, down from 2.8% in July and slightly above the preliminary estimate of 2.2%. Meanwhile, the ECB is widely anticipated to lower the deposit rate by 25 basis points to 3.50% later today, marking the second reduction this year, while market participants will seek hints on whether additional cuts in October and December remain on the table. In corporate news, Roche Holding Ag slid about -4% after the drugmaker revealed that the promising results of an early-stage trial for its experimental weight-loss pill were based on data from only six patients.
Germany’s WPI and Spain’s CPI data were released today.
The German August WPI arrived at -0.8% m/m, weaker than expectations of +0.1% m/m.
The Spanish August CPI came in at 0.0% m/m and +2.3% y/y, compared to expectations of 0.0% m/m and +2.2% y/y.
Asian stock markets today closed mixed. China’s Shanghai Composite Index (SHCOMP) closed down -0.17% and Japan’s Nikkei 225 Stock Index (NIK) closed up +3.41%.
China’s Shanghai Composite Index ended lower today, giving up early gains as weak sentiment in the country continued to weigh on the market. Liquor and telecom stocks led the declines on Thursday. The most recent set of economic data from China showed no clear signs of recovery, while authorities refrained from signaling market support through stronger policy measures. Geopolitical risks and trade tensions with other major economies further contributed to the bearish sentiment. Meanwhile, Bloomberg News reported on Thursday that China is set to reduce interest rates on over $5 trillion in outstanding mortgages as soon as this month. In other news, HSBC analysts believe that further monetary easing could be forthcoming, citing continued weakness in China’s domestic demand. In corporate news, Shanghai Guijiu plunged -10% after the liquor maker’s chairman and general manager, Han Xiao, was charged with alleged involvement in the illegal fundraising activities of Haiyin Wealth Management. Investors are now focusing on Chinese retail sales and industrial production data, set for release later this week.
Japan’s Nikkei 225 Stock Index closed sharply higher today, snapping a seven-day losing streak as the U.S. inflation reading drove the yen down from its highest level against the dollar since December. Technology and materials stocks led the gains on Thursday. The Bank of Japan reported Thursday that annual producer prices in Japan rose less than expected in August, marking the lowest level since April. Separately, the Cabinet Office reported that the business survey index for large manufacturers in Japan surged in the third quarter, showing positive growth for the first time in three quarters. Meanwhile, BOJ policy board member Naoki Tamura helped the yen recover from session lows with remarks about raising the BOJ benchmark rate to at least 1% by the end of its projection period. In other news, data from the Ministry of Finance revealed that overseas investors sold off a net 902.3 billion yen ($6.33 billion) of Japanese stocks in the week ending September 7th, marking the largest weekly foreign outflow in nearly six months. In corporate news, Seven & I Holdings gained over +4% after Bloomberg News reported that Canada’s Alimentation Couche-Tard was considering improving its takeover bid for the Japanese convenience store operator. The Nikkei Volatility, which takes into account the implied volatility of Nikkei 225 options, closed down -5.65% to 26.73.
The Japanese August PPI came in at -0.2% m/m and +2.5% y/y, weaker than expectations of 0.0% m/m and +2.8% y/y.
The BSI Large Manufacturing Conditions Index stood at +4.5 in the third quarter, stronger than expectations of -2.5.
Pre-Market U.S. Stock Movers
Oxford Industries plunged over -10% in pre-market trading after the clothing retailer posted downbeat Q2 results, issued below-consensus Q3 guidance, and cut its FY24 forecast.
Champions Oncology surged more than +15% in pre-market trading after the company reported better-than-expected Q1 results.
Today’s U.S. Earnings Spotlight: Thursday - September 12th
Adobe (ADBE), Kroger (KR), RH (RH), Signet Jewelers (SIG), Caleres (CAL), Lovesac (LOVE), MYT Netherlands (MYTE), Radiant (RLGT), IBEX (IBEX), Innate Pharma (IPHA), Farmer Bros. Co (FARM).
On the date of publication, Oleksandr Pylypenko did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policyhere.
With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Check out our premarket coverage here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.